Sonnerie VC

Sonnerie VC Fund I is a pre-seed fund in New York, backing U.S. healthcare and technology startups in regulated markets. Operator-led, it draws on the GPs’ on-thesis $1.3B strategic exit in this space. Born from the Columbia alumni network, and focused on impactful innovation. At Sonnerie VC, our mission is to amplify bold ideas. We back visionary founders building transformative solutions with lasting impact, empowering them with capital, operational insight, and a global network to scale their companies from signal to success. What is Sonnerie? An operator-led, pre-seed and seed venture firm. The first institutional check into university healthcare spinouts. What stage? Pre-seed and seed, the first institutional check at formation, with conviction through the seed round. What do you back? Therapeutics, medical devices, life sciences and diagnostics, and regulated health technology. Where? Across the United States, from New York, alongside university tech transfer offices and founders. We partner before there’s a company to partner with, alongside the founders and the tech transfer offices that hold the science.